Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major Treatment: a Multi-center, Open, Randomized, Controlled Clinical Study
Latest Information Update: 07 Dec 2018
At a glance
- Drugs Basiliximab (Primary) ; Ciclosporin; Methotrexate; Mycophenolate mofetil
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 22 Jan 2015 New trial record